Prebiotic Oligosaccharides: Comparative Evaluation Using In Vitro Cultures of Infants' Fecal Microbiomes
Authors:
Open Access
- 1 December 2014
- journal article
- research article
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 80 (23) , 7388-7397
Abstract
The objective of this study was to systematically assess the bifidogenic effect of three commonly used prebiotic products using in vitro cultures of infant fecal samples. Fresh stool samples collected from six term infants, each exclusively fed human milk ( n = 3) or infant formula ( n = 3), at 28 days of age were used as inocula. The following prebiotic products were added at concentrations applicable to infant formula: Vivinal GOS 15 (containing 28.5% galacto-oligosaccharide [GOS]) at 7.2 g/liter, Beneo HP (99.5% long-chain inulin [IN]) at 0.8 g/liter, Beneo Synergy 1 (enriched oligofructose and inulin [OF-IN]) at 4 g/liter, and a combination of Vivinal GOS 15 (7.2 g/liter) and Beneo HP (0.8 g/liter) (GOS-IN). The growth of total bacteria, Bifidobacterium , Bacteroides , Bifidobacterium longum , and Escherichia coli was quantified using specific quantitative PCR (qPCR). Bifidobacterium was also enumerated on selective Beerens agar plates, with representative colonies identified by sequencing of their 16S rRNA genes. Volatile fatty acids (VFA) and pH in the cultures were also determined. Irrespective of the feeding methods, the GOS product, either alone or in combination with Beneo HP, resulted in substantially higher growth of total bifidobacteria, and much of this growth was attributed to growth of B. longum . Beneo Synergy 1 also increased the abundance of total bifidobacteria and B. longum . Corresponding to the increases in these two bacterial groups, acetic acid concentrations were higher, while there was a trend of lower E. coli levels and pH. The lower pH and higher acetic acid concentration might be directly responsible for the lower E. coli population. At the concentrations studied, the GOS product was more bifidogenic and potent in inhibiting E. coli than the other products tested. These results suggest that supplementation of infant formula with GOS may increase intestinal bifidobacteria and benefit infant health.Keywords
This publication has 79 references indexed in Scilit:
- Utilization of galactooligosaccharides by Bifidobacterium longum subsp. infantis isolatesFood Microbiology, 2013
- Synbiotics, probiotics or prebiotics in infant formula for full term infants: a systematic reviewNutrition Journal, 2012
- Physiology of Consumption of Human Milk Oligosaccharides by Infant Gut-associated BifidobacteriaJournal of Biological Chemistry, 2011
- Human milk glycobiome and its impact on the infant gastrointestinal microbiotaProceedings of the National Academy of Sciences, 2010
- Molecular Ecological Analysis of Fecal Bacterial Populations from Term Infants Fed Formula Supplemented with Selected Blends of PrebioticsApplied and Environmental Microbiology, 2009
- Evaluations of Different Hypervariable Regions of Archaeal 16S rRNA Genes in Profiling of Methanogens by Archaea -Specific PCR and Denaturing Gradient Gel ElectrophoresisApplied and Environmental Microbiology, 2008
- Comparative Metagenomics Revealed Commonly Enriched Gene Sets in Human Gut MicrobiomesDNA Research, 2007
- Development and Application of Real-Time PCR Assays for Quantification of erm Genes Conferring Resistance to Macrolides-Lincosamides-Streptogramin B in Livestock Manure and Manure Management SystemsApplied and Environmental Microbiology, 2007
- Development of the Human Infant Intestinal MicrobiotaPLOS Biology, 2007
- Kinetics and Metabolism of Bifidobacterium adolescentis MB 239 Growing on Glucose, Galactose, Lactose, and GalactooligosaccharidesApplied and Environmental Microbiology, 2007